Zocor: Proven Cholesterol Control for Cardiovascular Health
Zocor
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.88 | $53.00 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $79.50 $72.00 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $106.00 $91.00 (14%) | 🛒 Add to cart |
| 180 | $0.72 | $159.00 $129.00 (19%) | 🛒 Add to cart |
| 270 | $0.69 | $238.50 $185.00 (22%) | 🛒 Add to cart |
| 360 | $0.66
Best per pill | $318.00 $239.00 (25%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.08 | $65.00 (0%) | 🛒 Add to cart |
| 90 | $1.00 | $97.50 $90.00 (8%) | 🛒 Add to cart |
| 120 | $0.96 | $130.00 $115.00 (12%) | 🛒 Add to cart |
| 180 | $0.93 | $195.00 $168.00 (14%) | 🛒 Add to cart |
| 270 | $0.91 | $292.50 $246.00 (16%) | 🛒 Add to cart |
| 360 | $0.89
Best per pill | $390.00 $321.00 (18%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.63 | $79.00 (0%) | 🛒 Add to cart |
| 60 | $1.90 | $158.00 $114.00 (28%) | 🛒 Add to cart |
| 90 | $1.67 | $237.00 $150.00 (37%) | 🛒 Add to cart |
| 120 | $1.54 | $316.00 $185.00 (41%) | 🛒 Add to cart |
| 180 | $1.43 | $474.00 $257.00 (46%) | 🛒 Add to cart |
| 270 | $1.34
Best per pill | $711.00 $361.00 (49%) | 🛒 Add to cart |
Synonyms | |||
Zocor (simvastatin) is a widely prescribed, HMG-CoA reductase inhibitor (statin) medication trusted by healthcare professionals for decades. It functions by effectively reducing the production of “bad” cholesterol (LDL) and triglycerides in the liver while moderately increasing levels of “good” cholesterol (HDL). This targeted action is clinically proven to slow the progression of atherosclerosis, significantly lowering the risk of major cardiovascular events such as heart attacks and strokes in at-risk patients. Its established efficacy and extensive safety profile make it a cornerstone in preventive cardiology and long-term lipid management strategies.
Features
- Contains the active pharmaceutical ingredient simvastatin.
- Available in multiple tablet strengths: 5 mg, 10 mg, 20 mg, 40 mg, and 80 mg.
- Administered orally, typically as a single daily dose.
- Works by selectively and competitively inhibiting the enzyme HMG-CoA reductase, a key rate-limiting step in the hepatic synthesis of cholesterol.
- Manufactured under strict quality control standards to ensure potency and purity.
Benefits
- Significant LDL-C Reduction: Lowers low-density lipoprotein cholesterol (LDL-C), the primary target of lipid-lowering therapy, by up to 50% depending on dosage.
- Reduced Cardiovascular Risk: Proven in large-scale clinical trials (e.g., the Scandinavian Simvastatin Survival Study - 4S) to reduce the risk of coronary mortality, non-fatal myocardial infarction, and the need for revascularization procedures.
- Improved Lipid Profile: Offers a comprehensive effect by also lowering triglycerides and apolipoprotein B, and moderately raising high-density lipoprotein cholesterol (HDL-C).
- Plaque Stabilization: Contributes to the stabilization of atherosclerotic plaques, making them less prone to rupture and cause acute thrombotic events.
- Well-Established Long-Term Safety: Decades of post-marketing surveillance and clinical use provide a robust understanding of its benefit-risk profile.
- Cost-Effective Therapy: As a generic medication, it provides a highly effective and accessible treatment option for a broad patient population.
Common use
Zocor is indicated as an adjunct to diet for the reduction of elevated total cholesterol, LDL-C, apolipoprotein B, and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia. It is also a key therapeutic agent for slowing the progression of coronary atherosclerosis and reducing cardiovascular events in patients with coronary heart disease (CHD) or those at high risk of developing CHD (e.g., patients with diabetes, peripheral artery disease, or a history of stroke). Its use is fundamental in both primary and secondary prevention strategies.
Dosage and direction
The dosage of Zocor must be individualized based on the patient’s baseline LDL-C level, the goal of therapy, and patient response. The usual starting dose is 10 or 20 mg once daily in the evening. Patients requiring large reductions in LDL-C (>45%) may be started at 40 mg/day. The maximum recommended dosage is 40 mg daily; the 80 mg dose is reserved for patients who have been taking it long-term (e.g., 12 months or more) without evidence of muscle toxicity. It can be taken with or without food. The tablet should be swallowed whole with a glass of water. Dosage adjustments are necessary when co-administered with certain drugs that increase simvastatin exposure.
Precautions
- Liver Function: Liver enzyme tests should be performed before initiating therapy, at 12 weeks following initiation or any dose elevation, and periodically thereafter.
- Muscle Effects: Patients should be advised to report promptly any unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever.
- Renal Impairment: While no dosage adjustment is typically needed for mild to moderate renal impairment, caution is advised in patients with severe renal insufficiency.
- Endocrine Function: Statins may affect glucose homeostasis. Hemoglobin A1c (HbA1c) and fasting serum glucose levels may increase.
- Cognitive Function: Rare cases of memory loss and confusion have been reported, which are generally not serious and reversible upon discontinuation.
Contraindications
- Hypersensitivity to simvastatin or any excipient in the formulation.
- Active liver disease or unexplained persistent elevations of serum transaminases.
- Concomitant use with strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, HIV protease inhibitors, boceprevir, telaprevir, erythromycin, clarithromycin, telithromycin, nefazodone, cobicistat-containing products).
- Concomitant use with cyclosporine, danazol, or gemfibrozil.
- Pregnancy and breastfeeding. Cholesterol is essential for fetal development, and the potential risk outweighs any benefit. It is also contraindicated in women of childbearing potential not using contraception.
Possible side effect
Like all medications, Zocor can cause side effects, although not everybody gets them. The most common are generally mild and transient.
- Very Common (≥1/10): Headache.
- Common (≥1/100 to <1/10): Constipation, nausea, dyspepsia, flatulence, abdominal pain, myalgia (muscle pain), asthenia (weakness).
- Uncommon (≥1/1,000 to <1/100): Pancreatitis, hepatitis, jaundice, paresthesia (tingling sensation), dizziness, insomnia, memory impairment, alopecia (hair loss), rash, pruritus (itching).
- Rare (≥1/10,000 to <1/1,000): Myopathy (muscle disease), rhabdomyolysis (muscle breakdown leading to kidney injury), peripheral neuropathy, lupus-like syndrome.
- Very Rare (<1/10,000): Anaphylaxis, angioedema, arthralgia (joint pain), erectile dysfunction, gynecomastia, depression, interstitial lung disease.
Drug interaction
Zocor has significant and potentially dangerous drug interactions due to its metabolism primarily by the cytochrome P450 3A4 (CYP3A4) pathway.
- Contraindicated: Strong CYP3A4 inhibitors (see Contraindications), gemfibrozil, cyclosporine, danazol.
- Use with Caution/Require Dose Limitation:
- Moderate CYP3A4 inhibitors: (e.g., diltiazem, verapamil, amiodarone, amlodipine, ranolazine). Do not exceed 10 mg simvastatin daily.
- Other Fibrates (except gemfibrozil): (e.g., fenofibrate). Increased risk of myopathy.
- Niacin (≥1 g/day): Increased risk of myopathy.
- Lopinavir/ritonavir: Do not exceed 20 mg simvastatin daily.
- Warfarin: Simvastatin may potentiate the anticoagulant effect; monitor INR closely.
- Digoxin: Concomitant use may slightly increase digoxin concentration.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered on the same day. If it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should not take a double dose to make up for the forgotten one. Maintaining a consistent daily routine is important for optimal efficacy.
Overdose
There is no specific antidote for simvastatin overdose. In the event of a suspected overdose, symptomatic and supportive measures should be instituted. The patient should seek immediate medical attention. Given the extensive protein binding of simvastatin, hemodialysis is not expected to significantly enhance its clearance. Liver function and CK levels should be monitored closely due to the increased risk of severe hepatotoxicity and rhabdomyolysis.
Storage
Store Zocor tablets at room temperature between 15°C and 30°C (59°F and 86°F). Keep the medication in its original container, tightly closed, and out of sight and reach of children. Protect from light and moisture. Do not store in bathrooms or near kitchen sinks. Do not use medicine that is past its expiration date. Properly discard any unused or expired medication.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or stopping any medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- Clinical Evidence (5/5): “The 4S study remains a landmark trial in cardiology. It irrefutably demonstrated that Zocor (simvastatin) reduces total mortality by 30% in patients with existing CHD over a 5.4-year period. This solidified the role of statins in secondary prevention.” – Cardiologist, 25 years of experience
- Efficacy & Tolerability (4.5/5): “In my practice, simvastatin is a workhorse. For most of my patients, the 20-40 mg dose range provides excellent LDL reduction with minimal side effects. Gastrointestinal complaints are the most common but are usually self-limiting.” – Internal Medicine Physician
- Patient Adherence (4/5): “The once-daily dosing, especially the availability of a generic formulation, makes it a highly accessible and adherent-friendly option for long-term management. It’s a foundational therapy I rely on for my high-risk patients.” – Clinical Pharmacist
- Safety Profile (4/5): “While we must remain vigilant for myopathy, particularly with higher doses and interacting drugs, the overall safety profile is well-characterized. The benefits of CV risk reduction in appropriate patients far outweigh the potential risks.” – Endocrinologist